{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T21:21:35Z","timestamp":1781817695739,"version":"3.54.5"},"reference-count":52,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T00:00:00Z","timestamp":1736121600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Fibroblasts in the fibrotic heart exhibit a heterogeneous biological behavior. The specific subsets of fibroblasts that contribute to progressive cardiac fibrosis remain unrevealed. Our aim is to identify the heart fibroblast (FB) subsets that most significantly promote fibrosis and the related critical genes as biomarkers for ischemic heart disease.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>The single nuclei RNA sequencing (snRNA-seq) and bulk RNA sequencing datasets used in this study were obtained from the Gene Expression Omnibus (GEO). The activity of gene sets related to progressive fibrosis was quantified for each FB cluster using the AddmoleculeScore function. Differentially expressed genes (DEGs) for the specific cell cluster with the highest fibrotic transcription dynamics were identified and integrated with bulk RNA sequencing data for analysis. Multiple machine learning models were employed to identify the optimal gene panel for diagnosing ischemic heart disease (IHD) based on the intersected DEGs. The effectiveness and robustness of the gene-derived diagnostic tool were validated using two independent IHD cohorts.Subsequently, we validated the signature genes using a rat post-myocardial infarction heart failure model.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>We conducted an analysis on high-quality snRNA-seq data obtained from 3 IHD and 4 cardiac sarcoidosis heart samples, resulting in the identification of 16 FB clusters. Cluster2 exhibited the highest gene activity in terms of fibrosis-related transcriptome dynamics. The characteristic gene expression profile of this FB subset indicated a specific upregulation of COL1A1 and several pro-fibrotic factors, including CCDC102B, GUCY1A3, TEX41, NREP, TCAP, and WISP, while showing a downregulation of NR4A1, an endogenous inhibitor of the TGF-<jats:italic>\u03b2<\/jats:italic> pathway. Consequently, we designated this subgroup as COL1A1<jats:sup>hi<\/jats:sup>NR4A1<jats:sup>low<\/jats:sup> FB. Gene set enrichment analysis (GSEA) shows that the gene expression pattern of COL1A1<jats:sup>hi<\/jats:sup>NR4A1<jats:sup>low<\/jats:sup> FB was closer to pathways associated with cardiac fibrosis. Through machine learning, ten feature genes from COL1A1<jats:sup>hi<\/jats:sup>NR4A1<jats:sup>low<\/jats:sup> FB were selected to construct a diagnostic tool for IHD. The robustness of this new tool was validated using an independent cohort and heart failure rats.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>COL1A1<jats:sup>hi<\/jats:sup>NR4A1<jats:sup>low<\/jats:sup> FB possess heightened capability in promoting cardiac fibrosis. Additionally, it offers molecular insights into the mechanisms underlying the regulation of the TGF-<jats:italic>\u03b2<\/jats:italic> pathway. Furthermore, the characteristic genes of COL1A1hiNR4A1 FB could serve as valuable tools for diagnosing of IHD.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fcvm.2024.1460813","type":"journal-article","created":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T07:01:08Z","timestamp":1736146868000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Enhanced fibrotic potential of COL1A1hiNR4A1low fibroblasts in ischemic heart revealed by transcriptional dynamics heterogeneity analysis at both bulk and single-cell levels"],"prefix":"10.3389","volume":"11","author":[{"given":"Cheng","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baoping","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luoxiang","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liqiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinglong","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangyang","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuluan","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanrui","family":"Mo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,1,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1016\/S0140-6736(17)32154-2","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990\u20132016: a systematic analysis for the global burden of disease study 2016","volume":"390","year":"2017","journal-title":"Lancet (London, England)"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1161\/CIRCULATIONAHA.113.004046","article-title":"The global burden of ischemic heart disease in 1990 and 2010: the global burden of disease 2010 study","volume":"129","author":"Moran","year":"2014","journal-title":"Circulation"},{"key":"B3","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/S0735-1097(01)01738-7","article-title":"A standardized definition of ischemic cardiomyopathy for use in clinic al research","volume":"39","author":"Felker","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1172\/JCI8040","article-title":"Disruption of the myocardial extracellular matrix leads to cardiac dysfunction","volume":"106","author":"Kim","year":"2000","journal-title":"J Clin Invest"},{"key":"B5","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1038\/nrm3904","article-title":"Remodelling the extracellular matrix in development and disease","volume":"15","author":"Bonnans","year":"2014","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1161\/CIRCRESAHA.116.303577","article-title":"The biological basis for cardiac repair after myocardial infarction: from inflammation to fibrosis","volume":"119","author":"Prabhu","year":"2016","journal-title":"Circ Res"},{"key":"B7","doi-asserted-by":"publisher","first-page":"2909","DOI":"10.1093\/eurheartj\/ehn416","article-title":"Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the task force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology","volume":"29","author":"Van de Werf","year":"2008","journal-title":"Eur Heart J"},{"key":"B8","doi-asserted-by":"publisher","first-page":"2351","DOI":"10.1161\/01.CIR.0000036014.90197.FA","article-title":"Left ventricular remodeling after primary coronary angioplasty: patter ns of left ventricular dilation and long-term prognostic implications","volume":"106","author":"Bolognese","year":"2002","journal-title":"Circulation"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/j.amjcard.2006.05.022","article-title":"Influence of transmurality, infarct size, and severe microvascular obstruction on left ventricular remodeling and function after primary coronary angioplasty","volume":"98","author":"Tarantini","year":"2006","journal-title":"Am J Cardiol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"e123","DOI":"10.1161\/CIR.0000000000000404","article-title":"2016 ACC\/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: a report of the American College of Cardiology\/American Heart Association task force on clinical practice guidelines: an update of the 2011 ACCF\/AHA\/SCAI guideline for percutaneous coronary intervention, 2011 ACCF\/AHA guideline for coronary artery bypass graft surgery, 2012 ACC\/AHA\/ACP\/AATS\/PCNA\/SCAI\/STS guideline for the diagnosis and management of patients with stable ischemic heart disease, 2013 ACCF\/AHA guideline for the management of ST-elevation myocardial infarction, 2014 AHA\/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes, and 2014 ACC\/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery","volume":"134","author":"Levine","year":"2016","journal-title":"Circulation"},{"key":"B11","doi-asserted-by":"publisher","first-page":"2549","DOI":"10.1093\/eurheartj\/ehac223","article-title":"Left ventricular remodelling post-myocardial infarction: pathophysiolo gy, imaging, and novel therapies","volume":"43","author":"Frantz","year":"2022","journal-title":"Eur Heart J"},{"key":"B12","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1038\/s41580-024-00716-0","article-title":"Fibroblast and myofibroblast activation in normal tissue repair and fibrosis","volume":"25","author":"Younesi","year":"2024","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1016\/j.jacc.2020.03.020","article-title":"Extracellular matrix in ischemic heart disease, part 4\/4: jACC focus seminar","volume":"75","author":"Frangogiannis","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/0014-4827(67)90113-9","article-title":"Alkaline phosphatase \u201cconstitutive\u201d clones: evidence for de-novo heterogeneity of established human skin fibroblast strains","volume":"45","author":"Papayannopoulou","year":"1967","journal-title":"Exp Cell Res"},{"key":"B15","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1146\/annurev-physiol-021119-034527","article-title":"Cardiac fibroblast diversity","volume":"82","author":"Tallquist","year":"2020","journal-title":"Annu Rev Physiol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.ejca.2021.03.005","article-title":"Applications of single-cell and bulk RNA sequencing in onco-immunology","volume":"149","author":"Kuksin","year":"2021","journal-title":"Eur J Cancer"},{"key":"B17","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/s41580-021-00407-0","article-title":"A guide to machine learning for biologists","volume":"23","author":"Greener","year":"2022","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1093\/bib\/bbaa122","article-title":"Structured sparsity regularization for analyzing high-dimensional omic s data","volume":"22","author":"Vinga","year":"2021","journal-title":"Brief Bioinform"},{"key":"B19","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1038\/s41586-022-05060-x","article-title":"Spatial multi-omic map of human myocardial infarction","volume":"608","author":"Kuppe","year":"2022","journal-title":"Nature"},{"key":"B20","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1038\/s41586-020-2797-4","article-title":"Cells of the adult human heart","volume":"588","author":"Litvi\u0148ukov\u00e1","year":"2020","journal-title":"Nature"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1093\/cvr\/cvaa324","article-title":"Cardiac fibrosis","volume":"117","author":"Frangogiannis","year":"2021","journal-title":"Cardiovasc Res"},{"key":"B22","doi-asserted-by":"publisher","first-page":"2617","DOI":"10.3390\/ijms23052617","article-title":"The pathogenesis of cardiac fibrosis: a review of recent progress","volume":"23","author":"Maruyama","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B23","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.matbio.2018.01.013","article-title":"Extracellular matrix remodeling and cardiac fibrosis","author":"Li","year":"2018","journal-title":"Matrix Biol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1161\/01.RES.0000046452.67724.B8","article-title":"Gene expression in fibroblasts and fibrosis: involvement in cardiac hy pertrophy","volume":"91","author":"Manabe","year":"2002","journal-title":"Circ Res"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1161\/CIRCRESAHA.115.306565","article-title":"Cardiac fibrosis: the fibroblast awakens","volume":"118","author":"Travers","year":"2016","journal-title":"Circ Res"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.3390\/ijms24021756","article-title":"Signaling pathways and potential therapeutic strategies in cardiac fibrosis","volume":"24","author":"Bertaud","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B27","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1038\/s41588-023-01337-7","article-title":"Dual genetic tracing reveals a unique fibroblast subpopulation modulat ing cardiac fibrosis","volume":"55","author":"Han","year":"2023","journal-title":"Nat Genet"},{"key":"B28","doi-asserted-by":"publisher","first-page":"3770","DOI":"10.1172\/JCI94753","article-title":"Fibroblast-specific TGF-\u03b2-Smad2\/3 signaling underlies cardiac fibrosis","volume":"127","author":"Khalil","year":"2017","journal-title":"J Clin Invest"},{"key":"B29","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1161\/CIRCRESAHA.123.322596","article-title":"TGF-\u03b21\/SMAD3 regulates programmed cell death 5 that suppresses cardiac fibrosis post-myocardial infarction by inhibiting HDAC3","volume":"133","author":"Weng","year":"2023","journal-title":"Circ Res"},{"key":"B30","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/s41392-022-00925-z","article-title":"Signaling pathways and targeted therapy for myocardial infarction","volume":"7","author":"Zhang","year":"2022","journal-title":"Signal Transduct Target Ther"},{"key":"B31","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1038\/nature07039","article-title":"Wound repair and regeneration","volume":"453","author":"Gurtner","year":"2008","journal-title":"Nature"},{"key":"B32","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1146\/annurev-pathol-020712-163930","article-title":"Host responses in tissue repair and fibrosis","volume":"8","author":"Duffield","year":"2013","journal-title":"Annu Rev Pathol: Mech Dis"},{"key":"B33","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1038\/nm.3777","article-title":"Orphan nuclear receptor NR4A1 regulates transforming growth factor-\u03b2 signaling and fibrosis","volume":"21","author":"Palumbo-Zerr","year":"2015","journal-title":"Nat Med"},{"key":"B34","doi-asserted-by":"publisher","first-page":"68","DOI":"10.3389\/fimmu.2020.00068","article-title":"Del-1, an endogenous inhibitor of TGF-\u03b2 activation, attenuates fibrosis","volume":"11","author":"Kim","year":"2020","journal-title":"Front Immunol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s12964-017-0175-0","article-title":"The role of TGF-\u03b2 and its crosstalk with RAC1\/RAC1b signaling in breast and pancreas carcinoma","volume":"15","author":"Melzer","year":"2017","journal-title":"Cell Communication and Signaling: CCS"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.3390\/cells11091386","article-title":"Properties and functions of fibroblasts and myofibroblasts in myocardial infarction","volume":"11","author":"Venugopal","year":"2022","journal-title":"Cells"},{"key":"B37","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1097\/HEP.0000000000000569","article-title":"Canonical wnt signaling promotes HSC glycolysis and liver fibrosis through an LDH-A\/HIF-1\u03b1 transcriptional complex","volume":"79","author":"Wang","year":"2023","journal-title":"Hepatology (Baltimore, Md)"},{"key":"B38","doi-asserted-by":"publisher","first-page":"5453","DOI":"10.1073\/pnas.1514854113","article-title":"Interaction of HIF1\u03b1 and \u03b2-catenin inhibits matrix metalloproteinase 13 expression and prevents cartilage damage in mice","volume":"113","author":"Bouaziz","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1038\/s41440-023-01219-9","article-title":"Upregulation of Piezo2 in the mesangial, renin, and perivascular mesen chymal cells of the kidney of dahl salt-sensitive hypertensive rats an d its reversal by esaxerenone","volume":"46","author":"Ochiai","year":"2023","journal-title":"Hypertens Res"},{"key":"B40","doi-asserted-by":"publisher","first-page":"2350","DOI":"10.1097\/HJH.0000000000001853","article-title":"Mechanical pressure unloading therapy reverses thoracic aortic structu ral and functional changes in a hypertensive rat model","volume":"36","author":"Korkmaz-Ic\u00f6z","year":"2018","journal-title":"J Hypertens"},{"key":"B41","doi-asserted-by":"publisher","first-page":"8836","DOI":"10.1080\/21655979.2022.2054913","article-title":"The crystallin alpha B (HSPB5)-tripartite motif containing 33 (TRIM33) axis mediates myocardial fibrosis induced by angiotensinogen II through transforming growth factor-beta (TGF-beta1)-Smad3\/4 signaling","volume":"13","author":"Wei","year":"2022","journal-title":"Bioengineered"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1161\/CIRCULATIONAHA.119.044914","article-title":"Secretome analysis of cardiomyocytes identifies PCSK6 (proprotein convertase subtilisin\/kexin type 6) as a novel player in cardiac remodeling after myocardial infarction","volume":"141","author":"Kuhn","year":"2020","journal-title":"Circulation"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1161\/CIRCULATIONAHA.109.863266","article-title":"Absence of thrombospondin-2 causes age-related dilated cardiomyopathy","volume":"120","author":"Swinnen","year":"2009","journal-title":"Circulation"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1161\/CIRCULATIONAHA.123.066298","article-title":"Versican promotes cardiomyocyte proliferation and cardiac repair","volume":"149","author":"Feng","year":"2024","journal-title":"Circulation"},{"key":"B45","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1161\/CIRCRESAHA.119.315999","article-title":"Glutamyl-Prolyl-tRNA synthetase regulates proline-rich pro-fibrotic protein synthesis during cardiac fibrosis","volume":"127","author":"Wu","year":"2020","journal-title":"Circ Res"},{"key":"B46","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1161\/HYPERTENSIONAHA.109.135665","article-title":"LIM And cysteine-rich domains 1 regulates cardiac hypertrophy by targeting calcineurin\/nuclear factor of activated T cells signaling","volume":"55","author":"Bian","year":"2010","journal-title":"Hypertension"},{"key":"B47","doi-asserted-by":"publisher","first-page":"2590","DOI":"10.1080\/15384101.2022.2105092","article-title":"Cancer-associated fibroblast-released extracellular vesicles carrying miR-199a-5p induces the progression of gastric cancer through regulation of FKBP5-mediated AKT1\/mTORC1 signaling pathway","volume":"21","author":"Wang","year":"2022","journal-title":"Cell Cycle (Georgetown, Tex)"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/2001-1326-3-1","article-title":"FKBP51 Increases the tumour-promoter potential of TGF-beta","volume":"3","author":"Romano","year":"2014","journal-title":"Clin Transl Med"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1093\/ecco-jcc\/jjad042","article-title":"Exosomal miR-103a-3p from crohn\u2019s creeping fat-derived adipose-derived stem cells contributes to intestinal fibrosis by targeting TGFBR3 and activating fibroblasts","volume":"17","author":"Qian","year":"2023","journal-title":"J Crohn\u2019s Colitis"},{"key":"B50","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1002\/jcp.31153","article-title":"17\u03b2-Estradiol Mediates TGFBR3\/Smad2\/3 signaling to attenuate the fibrosis of TGF-\u03b21-induced bovine endometrial epithelial cells via GPER","volume":"239","author":"Fang","year":"2023","journal-title":"J Cell Physiol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"3262","DOI":"10.1074\/jbc.M113.541052","article-title":"Glucocorticoids recruit Tgfbr3 and Smad1 to shift transforming growth factor-\u03b2 signaling from the Tgfbr1\/Smad2\/3 axis to the Acvrl1\/Smad1 axis in lung fibroblasts","volume":"289","author":"Schwartze","year":"2014","journal-title":"J Biol Chem"},{"key":"B52","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1097\/FJC.0b013e31821823d9","article-title":"Biomarkers of myocardial fibrosis","volume":"57","author":"de Jong","year":"2011","journal-title":"J Cardiovasc Pharmacol"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2024.1460813\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T07:01:12Z","timestamp":1736146872000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2024.1460813\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,6]]},"references-count":52,"alternative-id":["10.3389\/fcvm.2024.1460813"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2024.1460813","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,6]]},"article-number":"1460813"}}